IRD
Opus Genetics (IRD)
$14
About Opus Genetics (IRD)
Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.
Details
Daily high
$2.20
Daily low
$2.14
Price at open
$2.14
52 Week High
$2.59
52 Week Low
$0.65
Market cap
146.9M
Dividend yield
0.00%
Volume
237,962
Avg. volume
585,575
P/E ratio
-1.24
Opus Genetics News
Details
Daily high
$2.20
Daily low
$2.14
Price at open
$2.14
52 Week High
$2.59
52 Week Low
$0.65
Market cap
146.9M
Dividend yield
0.00%
Volume
237,962
Avg. volume
585,575
P/E ratio
-1.24